U.S. stock futures were higher this morning, with the Nasdaq 100 futures gaining around 1% on Monday.

Shares of Novo Nordisk A/S (NYSE:NVO) fell sharply in pre-market trading after the company released topline results from Phase 3 REIMAGINE 5 and REDEFINE 9 trials of once-weekly Cagrisema (Cagrilintide and Semaglutide).

Novo Nordisk shares dipped 4.8% to $41.15 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

• Aligos Therapeutics Inc (NASDAQ:ALGS) fell 15.1% to $4.45 in pre-market trading.
• Telix Pharmaceuticals (NASDAQ:TLX) fell 7.9% to $11.60 in pre-market trading. Telix Pharmaceuticals signed a strategic agreement to lead a merger with ITM Isotope Technologies Munich SE.
• Perspective Therapeutics Inc (NYSE:CATX) fell 7.3% to $2.67 in pre-market trading.
• Stewards Inc (NASDAQ:SWRD) declined 7% to $2.00 in pre-market trading.
• Li Auto Inc (NASDAQ:LI) fell 3.5% to $11.72 in pre-market trading. Li Auto, last week, announced the launch of its flagship Li i9 SUV, priced at RMB369,800 for its standard configuration.
• New Pacific Metals Corp (NYSE:NEWP) fell 3.3% to $5.80 in pre-market trading.
• Inventiva SA – ADR (NASDAQ:IVA) declined 2.7% to $3.68 in pre-market trading.

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.